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Abstract
In placental malaria, Plasmodium falciparum-infected erythrocytes adhere to the apical plasma membrane of the placental
epithelium, triggering an impairment of placental function detrimental to the fetus. The design of anti-adhesion
intervention strategies requires a detailed understanding of the mechanisms involved. However, most adhesion assays lack
in vivo relevance and are hardly quantitative. Here, we describe a flow cytometry-based adhesion assay that is fully relevant
by using apical epithelial plasma membrane vesicles as the adhesion matrix, and being applicable to infected erythrocytes
directly isolated from patients. Adhesion is measured both as the percentage of pathogens bound to epithelial membrane
vesicles as well as the mean number of vesicles bound per infected erythrocytes. We show that adhesins alternative to those
currently identified could be involved. This demonstrates the power of this assay to advance our understanding of epithelial
adhesion of infected erythrocytes and in the design of intervention strategies.
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Introduction
Polarized epithelia line organs such as the stomach and
intestines, lung, and placenta. They are the first line of defense
against a variety of pathogens, many of which have developed
mechanisms to adhere to epithelia to survive in their host.
Pathogens can either adhere directly to the epithelium, or infect
and modify host cells to cause adhesion. These pathogens are
highly prevalent and range from viruses like the cytomegalovirus
to bacteria like Helicobacter pylori or parasites such as the malaria
agent Plasmodium falciparum. The health and economic impacts of
these infections are immense.
Epithelial adhesion is the first step in the pathogenetic process of
such pathogens. In some cases, adhesion may also allow a
pathogen to evade clearance. Altered function of the epithelium
may be followed by epithelial cell damage or destruction, and
invasion into normally sterile sites such as the blood stream or the
lung parenchyma. Decreased host fitness, and ultimately death,
may occur.
Strategies aimed at preventing pathogen epithelial adhesion are
needed and require a complete understanding of the underlying
molecular mechanisms. This can only be achieved through
adequate adhesion assays. However, assays currently available to
address epithelial adhesion of pathogens have serious limitations.
Most current assays use an adhesion matrix with no or limited
relevance to the apical membrane of the epithelium studied. Some
assays use cell lines (either non-polarized or artificially polarized)
but these hardly model the host’s epithelium [1] and expression
profiling and functional studies of these cells suggest they often are
quite different from the epithelium they intend to model [2]. Other
assays make use of previously identified pathogen receptors
adsorbed on plastic as an adhesion matrix and are obviously
limited in their scope [3]. The receptors lack their in vivo molecular
context; they may not be correctly folded and receptor synergy
cannot be studied. As such, they may not support pathogen
adhesion in the same manner or to the same extent as the native
receptor [4]. Animal models also have limitations, as adhesion
does not always occur at the same anatomical site as in the natural
host [5] and the anatomical and histological characteristics of the
target and human epithelia may differ [6].
Model pathogens are not always representative of those
infecting the natural host, and some pathogens cannot be
modeled, either because they cannot be maintained in culture or
because they cannot infect laboratory animals (for example, S.
enterica serotype Typhi can only infect humans [7]). Moreover,
adaptation to culture conditions is associated with profound
changes in the expression of virulence factors or adhesion
phenotype in some pathogens [8,9,10].
Adhesion can quickly trigger a response from both the pathogen
(invasion of the epithelium) and the epithelium (alteration of cell
surface expression patterns) complicating the investigation of the
early stages of adhesion in cellular or animal models [11]. An
acellular assay would advance the dissection of the mechanisms
underlying pathogen adhesion without interference from the
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pathogens are needed given the global health impact of these
diseases. The successful design and validation of these anti-
adhesion approaches requires an adhesion assay able to quanti-
tatively measure adhesion and to easily and rapidly test the
adhesion-blocking capacity of candidate therapeutics. However,
most current assays are not quantitative and almost all are low
throughput.
Here, we describe a novel assay that addresses these issues: it
uses apical plasma membrane vesicles of the target epithelium as
adhesion matrix and is applicable to pathogens directly isolated
from infected hosts. Being an acellular approach using an isolated
epithelial plasma membrane, it allows the investigation of the
mechanisms of adhesion without interference from the epithelium
response. The use of flow cytometry makes it quantitative,
objective, reproducible and high throughput. Its use should both
advance our basic knowledge of the mechanisms of epithelial
adhesion as well as allow the design and validation of anti-
adhesion strategies.
We applied this innovative adhesion assay to malaria-infected
erythrocyte placental adhesion. After invasion of an erythrocyte, P.
falciparum exports molecules to the surface of the infected cell.
Some of these molecules support the adhesion of the infected
erythrocyte to host tissues, including to the placental epithelium.
Adhesion of P. falciparum-infected erythrocytes (IE) to the placenta
can trigger local inflammation leading to placental impairment
and fetal growth restriction [12]. A more complete understanding
of the mechanisms involved in the placental adhesion of IE is
required, so that strategies to prevent adhesion can be developed
to improve maternal and fetal health. The mechanisms underlying
the placental adhesion of IE are relatively well documented [12],
offering a reliable way to validate our assay. Current understand-
ing is that VAR2CSA, a parasite protein exported to the surface of
the IE, binds to chondroitin sulfate A (CSA) expressed on the
apical membrane of the placental syncytiotrophoblast epithelium,
and high levels of antibodies against CSA-binding parasite lines
are associated with better pregnancy outcomes [13]. However,
research that has focused on the VAR2CSA/CSA interaction has
largely ignored other potential parasite adhesins and placental
receptors.
Results
Assay principle
Based on their highly negative surface charge density, the apical
plasma membrane of several epithelia can be purified using a
protocol based on Mg
2+ precipitation and differential centrifuga-
tion [14]. Such plasma membrane fragments when isolated from
human placenta and then forced to vesiculate by shear force,
orientate right-side-out (i.e. the same orientation with respect to
cytoplasm in vivo) [14]. The vesicles of the apical plasma
membrane so generated (hereafter referred to as ‘vesicles’) are
then labeled using a non-specific fluorescent lipid dye (PKH67 in
this case) before being co-incubated with the pathogen of interest.
Being non-specific, the lipid dye used is less likely to interfere with
adhesion. If needed for identification, the pathogen can be
fluorescently labeled (using ethidium bromide to stain its DNA for
example). Vesicles that are not bound to pathogens are washed off
before acquisition on a flow cytometer (Figure 1). Adhesion is
quantified both as the percentage of pathogens bound to vesicles
(percentage adhesion) as well as the mean PKH67 fluorescence
intensity of vesicle-bound pathogens (adhesion intensity). A follow-
up of the adhesion levels and intensity during flow cytometry
acquisition reveals that the acquisition of as few as 950 pathogens
(acquired in 8 seconds) are needed to obtain data statistically
representative of the sample (data not shown).
The purity of the apical plasma membrane vesicle preparations
was measured by determining the enrichment in alkaline
phosphatase activity, a marker of the apical plasma membrane,
as compared to the starting tissue homogenate [14]. The
enrichment factors for the vesicles used in this study (median:
25.5; IQR: 22.91–34.07) accord well with previous values and
indicate a high degree of purity.
Assay validation: Plasmodium falciparum-infected
erythrocytes adhesion to the placenta
We confirmed that our adhesion assay could recapitulate known
features of the adhesion of IE to the placenta. By applying it to
var2csaKO parasites, thereby abolishing the opportunity for
VAR2CSA/CSA interaction, we investigated whether alternative
adhesins could mediate placental adhesion.
Figure 1. Assay principle. (a.) The epithelial microvillous plasma membrane (MVM) is purified from the host epithelium (the syncytiotrophoblast,
or SCT, layer of the human placenta in this case) and forced to vesiculate. Vesicles labeled with the fluorescent lipid dye PKH-67 are co-incubated with
pathogens (ethidium bromide-stained P. falciparum-infected erythrocytes (IE) of the placental-type line CS2 in this example). Unbound vesicles are
washed off prior to acquisition on a flow cytometer. (b.) A typical cytogram shows that 33% of IE (ethidium bromide
+ erythrocytes) have bound
vesicles detected by their PKH67 fluorescence. The adhesion intensity is measured by the mean PKH67 fluorescence intensity (MFI) of pathogens
bound to vesicles (243 in the example given). (c.) The PKH67 MFI of pathogens bound to vesicles is used to calculate the average number of vesicles
bound per pathogen by dividing it by the PKH67 MFI of the vesicles used derived from the histogram shown. In the example given, each IE that
adhered to vesicle was bound to an average of 243/71.64=3.4 vesicles.
doi:10.1371/journal.pone.0021126.g001
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volume of vesicle suspension to be used in comparative
experiments, we measured adhesion as a function of increasing
volume of vesicle suspension both as percentage adhesion (the
percentage of IE with one or more PKH67-labeled vesicle bound)
and adhesion intensity (PKH67 MFI of vesicle bound-IE)
(Figure 2).
Number of vesicles per IE. The number of vesicles bound
per IE was estimated by dividing the PKH67 MFI of vesicle-
bound IE by that of vesicles alone, as described in Figure 1.
Extrapolation of the data shown in Figure 2 predicted that the
average number of vesicles/IE would start plateauing at
3.9860.22. This is further supported by imaging of 2 to 4
vesicles at the surface of IE using either immunofluorescence
(using an anti-placental alkaline phosphatase antibody) or
scanning electron microscopy (Figure 3).
Variation in the ability of different parasite lines to bind to
vesicles from different placentas. Vesicles were prepared
from placentas from seven different women, and their capacity to
support adhesion of CSA-binding parasites was compared at similar
vesicle/IE ratios (Figure 4a). Despite being of comparable density,
purity and mean fluorescence intensity, these different vesicles
showed significant variation in their capacity to support adhesion.
We used four different vesicle preparations (vesicles A to D from
Figure 4a) to compare the binding levels of four placental-type
parasite lines from different geographical origins [15]: Pf2004-
CSA (West African), HB3-CSA (from Central America), CS2
(presumed from Brazil) and XIE-CSA (from Papua New Guinea).
All parasite lines bound at high levels to CSA, and were tested at a
parasitemia of 5% mature adhering trophozoite stages. When each
parasite line was incubated with the same volume of the various
vesicle preparations, we found a large variation in the ability of
different lines to adhere to vesicles.
Recapitulation of known features of P. falciparum
placental adhesion
In order to validate our adhesion assay, we examined known
characteristics of malaria parasite placental adhesion [12]
(Figure 5).
After invasion of an erythrocyte, P. falciparum progresses from
the ring stage that expresses few adhesins at its surface to the
mature trophozoite stage at which the surface expression of
adhesins is maximal. A culture of the CSA-binding CS2 line
containing both ring and trophozoite stages was incubated with
vesicles. As expected, the percentage of vesicle-binding ring stage
IE was low (4.3%) when normalized to trophozoite stage IE,
confirming the late stage specificity of IE adhesion to vesicles
[3,16].
Adhesion of IE to the placenta is specific for parasites infecting
pregnant women [17]. This feature was recapitulated in our assay
Figure 2. Adhesion level and intensity. Vesicles were prepared from three different placentas (denoted by the white, light grey and dark grey
bars) and adjusted to the same density. Increasing volumes of these vesicles (5 to 100 mL) were incubated with the placental-type line CS2. (a.)
Despite the similar purity and mean fluorescence levels of the various vesicle preparations, the percentage of IE with adherent vesicles varied
significantly across vesicle preparations and increasing the volume of vesicles had a strong impact on the adhesion levels associated with some, but
not all, vesicle preparations. (b.) This difference was not mirrored by differences in adhesion intensity (measured as the PKH67 MFI of vesicle bound-
IE), which increased in proportion to vesicle volume for all vesicle preparations. Data are shown as mean and standard deviation from experimental
triplicates.
doi:10.1371/journal.pone.0021126.g002
Figure 3. Adhesion intensity. (a.) Immunofluorescence with a
vesicle-specific anti-placental alkaline phosphatase (PLAP) antibody and
DAPI to stain the parasite DNA reveals a small number (2–4) of vesicles
at the surface of IE. (b.) This is confirmed by scanning electron
microscopy in which vesicles have been false-colored in green. Knob-
like structures seen at the surface of the IE result from the extensive
remodeling of the erythrocyte membrane by Plasmodium falciparum
molecules. Bar size: 1 mm. Parasite line used: CS2.
doi:10.1371/journal.pone.0021126.g003
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only 5.1% of the level observed with CS2 IE.
We next demonstrated a major role for the VAR2CSA/CSA
interaction in adhesion of IE to placental vesicles [18]. Cleaving
CSA from vesicles with chondroitinase ABC inhibited the
adhesion of placental-type IE by 50.1% (65.5%), and pre-coating
of IE with soluble CSA reduced binding to vesicles by 88.8%
(61.4%). The disruption of the var2csa gene in CS2 reduced
adhesion by 95.5% (60.9%) compared to parental CS2 IE
(Figure 5a).
In malaria-endemic areas, women in their first pregnancy
(primigravidae) are immunologically naı ¨ve to placental-type
parasites, but a humoral immunity is developed through successful
pregnanciesand multigravidaehave high levelsofantibodiesagainst
placental-type parasites. One function of these antibodies is to block
the adhesion of IE to the placenta. We compared the adhesion-
inhibition capacity of serum samples from primigravidae, secundi-
gravidae and multigravidae to sera from non-pregnant controls. As
expected, the adhesion of the placental-type parasite line CS2 to
vesicles was inhibited in a parity-dependent manner (Figure 5b).
Figure 4. Inter-vesicle and inter-parasite line variations in adhesion. (a.) Vesicles were prepared from seven different placentas (A to G) and
incubated with IE of the CSA-binding line CS2 at identical vesicle/IE ratios. The percentage of adhesion (percentage of IE with bound vesicles) shows a
marked difference in the ability of preparations from different donors to bind to CS2 IE. (b.) Four vesicle preparations representative of the range of
CS2 adhesion levels observed were selected (A to D) and adhesion levels of four different CSA-binding lines from various geographical origins were
measured. A hierarchy exists amongst parasite lines as, regardless of the vesicle preparation used, CS2 shows the highest adhesion levels amongst all
parasite lines tested. Such a hierarchy is not found across vesicle preparations as CS2 binds best to vesicles D, whereas other lines adhere better to
vesicles C. Results are expressed as mean and standard deviation from experimental triplicates. Data representative of two independent experiments
are shown.
doi:10.1371/journal.pone.0021126.g004
Figure 5. Recapitulation of known characteristics of malaria parasite placental adhesion. (a.) When normalized to the adhesion levels of
VAR2CSA-expressing, CSA-binding placental-type trophozoites (CS2 line), earlier parasite ring stages show very limited binding. Trophozoites of the
non-CSA binding parental line E8B (non-placental type) do not show significant adhesion to vesicles. The inhibition of adhesion of placental-type
trophozoites by the disruption of var2csa (var2csaKO), treatment of vesicles with chondroitinase ABC or pre-incubation of IEs with soluble CSA
suggests that most of the adhesion is VAR2CSA/CSA mediated. Data are shown as mean and standard deviation from experimental triplicates. (b.)
The assay could also detect a parity-dependent adhesion inhibition by sera from malaria-exposed pregnant women. When normalized to the
adhesion intensity in the absence of serum, sera from non-pregnant controls from Melbourne (Melb. CTR) did not induce any significant decrease in
adhesion intensity whereas a pool of patients’ sera selected for their high immunoglobulin titers against CS2 did. Sera from malaria-exposed
pregnant women showed a parity-dependent increase in their adhesion blocking capacity. Boxes show the median, 25
th and 75
th percentiles and
whiskers are 5
th and 95
th percentiles from all sera tested in triplicates. *: p=0.046; **: p#0.0003.
doi:10.1371/journal.pone.0021126.g005
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adhesins involved in placental malaria
Our assay uses the actual membrane IE adhere to in vivo,s oi ti s
ideal to identify all potential parasite adhesins (and placental
receptors) supporting IE placental adhesion. Since var2csa
disruption did not totally suppress placental adhesion (Figure 5a),
parasite adhesins other than VAR2CSA could mediate placental
adhesion. We used var2csaKO IE repeatedly selected for their
capacity to adhere to the placental cell line BeWo [19] as a model
for a non-VAR2CSA expressing placental-type parasite line. The
adhesion levels and intensity of this selected KO were compared to
the wild type parasites (Figure 6). The selected KO showed
reproducibly high levels of binding to vesicles (100%62.63%)
despite a 30% decrease in adhesion intensity compared to the wild
type line. This suggests that parasite adhesins, other than
VAR2CSA, can mediate very significant levels of placental
adhesion. Their identification is crucial for the design of a fully
protective vaccine against placental malaria.
Discussion
Adhesion to the apical membrane of polarized epithelia is a key
pathogenetic process of a variety of pathogens, including the
malaria parasite P. falciparum. Studying the mechanisms underlying
adhesion with a relevant, high throughput and quantitative assay
would allow a better understanding of those mechanisms.
Ultimately, this could also help in the design and validation of
adhesion-blocking strategies aimed at improving health outcomes.
Superiority over other assays
Most available adhesion assays lack relevance, either because of
the adhesion matrix or the model pathogen they use. Because of
these limitations, data generated from these assays must be treated
with caution. As shown in Figure 6, model cell lines or, a fortiori
isolated receptors, may not recapitulate the complex molecular
profile of the apical epithelial membrane as well as vesicles can. By
using the actual plasma membrane that a pathogen adheres to in
vivo, and by being applicable to pathogens directly isolated from
their host, our innovative adhesion assay brings a high level of
relevance to the fundamental research into the mechanisms
underlying epithelial adhesion of pathogens. In parallel, the use of
flow cytometry allows the rapid and objective quantification of
adhesion and opens avenues of research into the design and
validation of adhesion-blocking strategies through drug discovery
or vaccine design. To our knowledge, our adhesion assay is the
only one to integrate adhesion matrix and pathogen relevance as
well as high-throughput.
Adaptability of the approach to other polarized epithelia
and pathogens
We chose to validate our approach by applying the assay to the
adhesion of malaria-infected cells to the placenta as the bases for
this adhesion are well documented [12] and this pathogen can be
cultured in vitro. However, the Mg
2+ precipitation and differential
centrifugation approach used to purify the apical membrane of the
placental epithelium has been successfully applied to other
epithelia with little or no modification [20,21,22]. The low
number of pathogens required in the assay, allows its application
to field isolates prior to their adaptation to culture. Finally, the
quantity of starting material needed to purify apical epithelial
vesicles is small and 5 assays can be performed on vesicles purified
from only 10 g placental villous tissue (about 3% of the total
weight of the human placenta). We are therefore confident that the
approach we describe can successfully be transferred to other
epithelia which have a microvillous surface with a highly negative
surface charge density (such as intestine) and to other pathogens
provided the pathogens could be isolated or cultured and
fluorescently labeled, allowing detection by flow cytometry.
Limitations of our assay
The main limitation of our assay is the lack of controllable and
measurable shear stress between the vesicles and the pathogen,
making it difficult to test the strength of the adhesion. It would be
possible to immobilize the vesicles (for example by capturing them
using a specific antibody) and run an adhesion assay under
controlled flow conditions. However, in most cases, the in vivo
shear stress between these epithelium-adhering pathogens and the
membrane they adhere to is quite low [23,24]. Another constraint
of our assay is that the pathogen being investigated must be
detectable by flow cytometry. This implies that its size must be
between 1 and 150 mm and that, in the case of intracellular
pathogens, infected cells must be distinguishable from non-infected
cells. Epithelium-binding pathogens comprising mainly bacteria or
parasites, fall mostly within this size range and their membrane
could be easily stained with non-specific lipid dyes or DNA stains
as used in the assay here. Interactions between viruses and
epithelia may be more challenging to study.
Some other potential uses of the assay
As demonstrated here in the application of the assay to placental
malaria, one or more of the three components of the assay can be
altered: vesicles, pathogen and co-incubation medium. For
example, by cleaving specific receptors from the surface of the
vesicles using an enzymatic treatment, it can be determined
whether individual receptors are involved in adhesion and, if so, to
what extent. One could also compare adhesion profiles of
pathogens presenting different phenotypes and discover which
one best correlates with adhesion. The co-incubation medium can
also be altered to test the impact of exogenous agents on adhesion
characteristics. Finally, being a flow-cytometry based assay, sorting
of either pathogens and/or vesicles based on adhesion character-
istics is feasible. For example, comparing the transcriptomes and
surface molecule expression profiles of pathogens that do or do not
Figure 6. Adhesins other than VAR2CSA support adhesion to
the placental epithelium. CS2 IE with disrupted var2csa were
selected on BeWo cells for adhesion. In comparison to wild type CS2 IE,
they bound at very low levels to isolated CSA. Their adhesion to the
BeWo placental cell line was about half that of the wild type IE.
However, in our vesicle adhesion assay, this BeWo-selected var2csaKO
showed similar percentages of IE bound to vesicles (p=0.7728) as well
as comparable adhesion intensity (p=0.2454) to wild type CS2. All
results are normalised to wild type levels and represented as mean and
standard deviation.
doi:10.1371/journal.pone.0021126.g006
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molecules involved in adhesion. Also, epithelial membranes could
be selected and isolated prior to the assay based on the expression
of specific membrane markers. This is particularly useful when the
epithelium is composed of various cell types such as the intestinal
epithelium. For example, it has been shown that Shigella flexneri,a
gram-negative bacteria causing diarrhea in humans, only adheres
to M cells but there is no good model for these cells. Selecting
membranes from M cells (based on their reactivity with mAb
NKM 16–2–4 [25]) would allow, for the first time, to address the
adhesion of S. flexneri specifically to the plasma membrane of these
cells.
Meaning of the new data generated on Plasmodium
falciparum
By applying our assay to placental adhesion of Plasmodium
falciparum-infected erythrocytes, we have validated our approach
but also generated novel and important data.
Inter-vesicle variations in adhesion levels. Various vesicle
preparations showed a wide variation in their capacity to support
the adhesion of CSA-binding IE. Given the heterogeneity of the
placental transcriptomes across anatomical sites [26,27], vesicles
prepared from various placental regions could support IE adhesion
at different levels. However, given that villous tissue used to obtain
each vesicle preparation was sampled from many sites in the
placenta representative of the whole organ, the low inter-
experiment variability of our assay (7%), and the comparable
density, purity and mean fluorescence intensity of vesicle
preparations, this variation in adhesion levels is likely to be due
to qualitative differences between vesicle preparations and implies
some degree of donor/biological variation, which could be an
important predisposing factor to disease. Investigating further the
bases of this donor variation would improve our understanding of
placental adhesion and may lead to the identification of novel
placental receptors or parasite variants with differential adhesion
capacity. Adhesion percentages varied greatly across vesicle
preparations but adhesion intensity was similar, suggesting that
the difference between vesicle preparations may lie in the avidity
of these vesicles for IE. Differential expression of CSA across
vesicle preparations may explain the range of adhesion
percentages observed. However, this would not account for the
lack of hierarchy amongst vesicles when tested against different
placental-type parasite lines (Figure 4b) unless the various parasite
lines tested adhere to vesicles through different mechanisms.
Number of vesicles/IE. Considering the relatively small
average diameter of the vesicles (6150 nm) compared to the
infected erythrocyte (67 mm), the adhesion of only 2–4 vesicles/IE
cannot be explained by steric hindrance. In a similar assay
examining adhesion of platelet microparticles to IE, similar
numbers of platelet microparticles bound to IE were observed
[28]. This low number of vesicles/IE could occur if the placental
receptor is not uniformly expressed at the apical membrane, so
that only a proportion of vesicles would express a placental
receptor that can bind to IE and vesicles would therefore be
limiting. This is unlikely given that the average number of
vesicles/IE did not dramatically change with increasing vesicle/IE
ratios, whereas adhesion levels did (Figure 2). Instead, we
hypothesize that the knobs, these electron-dense molecular
structures in which most IE adhesins reside, are not identical
and that differences in the maturity and/or composition of knobs,
as recently described [29], may explain low numbers of vesicles
binding. The result of these variations may be that relatively few
knobs can actually mediate placental adhesion.
Adhesion of var2csaKO IEs. BeWo-selected var2csaKO IE
adhere to placental vesicles at the same level as the wild type
placental-type line. This suggests that parasite molecules, other
than VAR2CSA, can mediate high levels of placental adhesion. It
is important to note that these IE do not consistently show the sex-
specific, parity-dependent pattern of recognition by maternal
antibodies typical of pregnancy-type parasites which could mean
that such IE have a limited role in the pathogenesis of placental
malaria. However, if one assumes that VAR2CSA is the default
adhesin used by IE to adhere to the placenta and that adhesion-
blocking immunity to VAR2CSA only develops after 2–3
successful pregnancies, alternative adhesins would only be
expressed and engaged by parasites found in multigravidae and
one would not be able to detect a parity-dependent recognition of
these var2csaKO IE by maternal sera. The identification of the
placental receptors supporting adhesion of these var2csaKO IE to
vesicles would involve comparing the molecular profiles of vesicles
that adhered or not to such IE. This is important in the context of
placental malaria vaccine design.
A better understanding of the mechanisms underlying the
pathogenetic process of epithelial adhesion of pathogens is needed.
By its relevance, both in terms of adhesion matrix and pathogen,
our innovative assay is powerful at defining key molecular
epithelium-pathogen interactions. Being quantitative and high-
throughput, it will be a valuable tool for the design and validation
of adhesion-blocking strategies. With the capacity to be used in
fundamental research as well as in drug discovery, and to be
applied to various pathogens and epithelia with minimal or no
modifications, our innovative assay is likely to assist a large
number of teams in their research in host-pathogen interactions.
Methods
Purification of apical epithelial vesicles
Placentas were obtained after written informed consent from
participants delivering by elective caesarian section at the Royal
Women’s Hospital, Melbourne. The study was approved by the
Human Research Ethics Committee of the Royal Women’s
Hospital (project 08/33). All participants had uncomplicated
pregnancies and delivered healthy singletons at term. Vesicles of
the syncytiotrophoblast microvillous membrane were prepared
within 30 minutes of delivery as described previously [14]. Briefly,
the microvillous plasma membrane is sheared off the surface of the
villi by isotonic tissue homogenization. Non-microvillous mem-
branes are then aggregated by Mg
2+ precipitation, allowing the
isolation of the microvillous plasma membrane by differential
centrifugation. Purified microvillous plasma membrane is then
vesiculated by repeated passages through a 25G needle. Vesicles
are stored at -80uC. The purity of the vesicle preparations was
determined by the enrichment of alkaline phosphatase (AP, a
specific marker of the microvillous membrane) compared to the
starting placental homogenate [14]. Briefly, AP activity in
placental homogenate and vesicles was quantified by the rate of
conversion of p-nitrophenylphosphate at pH 9.8 over 2 minutes.
Results were normalized to the protein concentration for each
sample (determined by Lowry assay). Enrichment factor in AP was
calculated as the ratio of AP activity in vesicles to initial placental
homogenate. Before use in adhesion assays, vesicle preparation
density was determined by flow cytometry acquisition against a
reference fluorescent beads suspension of known density.
Plasmodium falciparum culture
Malaria parasite lines were cultured in blood group O
+ human
erythrocytes, supplied by the Australian Red Cross Blood Service,
Adhesion Assay for Placental Malaria
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lines used were E8B (a non-placental type line) and the placental
type lines CS2 (derived from E8B by selection on CSA), Pf2004-
CSA, HB3-CSA and XIE-CSA (each panned on CSA to give high
levels of CSA adhesion). A var2csaKO was previously generated on
a CS2 background and was selected to bind to the trophoblast cell
line BeWo [19].
Adhesion assay
Vesicles were stained by PKH67 (Sigma), a fluorescent lipid
dye, according to supplier’s instructions and incubated for 1 h
under gentle agitation with IE at 1% haematocrit and at least 5%
parasitemia in adhesion medium (RPMI 1640–N-2-hydroxyethyl-
piperazine-N9-2-ethane sulphonic acid (HEPES) medium with
0.2% w/v NaHCO3 and 10% pooled heat-inactivated non-
immune human serum, pH 7.2) in a final volume of 150 mLi n9 6 -
well U-bottom newborn calf serum-coated culture plates. Ethi-
dium bromide (100 mg/mL final) was added for 15 minutes to
stain parasites’ DNA before washing off unbound vesicles by 3
centrifugation steps at 500 g for 3 minutes. After fixation in 0.5%
formaldehyde, tubes were acquired using a FACSCalibur. A
minimum of 10,000 IEs (EtBr
high erythrocytes) was acquired. A
PKH67 fluorescence threshold was set using a negative control (IE
without vesicles) so that 1% of IE was considered PKH67-positive.
The readouts were the percentage of IE bound to vesicles among
IE (percentage of adhesion) and the mean PKH67 fluorescence
intensity (MFI) of IE (adhesion intensity).
Adhesion of IE to BeWo cells was quantified as described
previously [19].
For adhesion-inhibition assays, IE were incubated with
participants’ sera (final dilution 1/10, 0.5% haematocrit) for
30 minutes at room temperature with constant agitation before
performing the adhesion assay. In order to test the importance of
VAR2CSA/CSA interaction in IE adhesion to vesicles, IE were
incubated with 100 mg/mL of soluble CSA form bovine trachea
(Sigma C9819) for 30 minutes at room temperature with constant
agitation or vesicles were treated with chondroitinase-ABC (Sigma
C3667; 0.1 IU/mL final) for 30 minutes in PBS with 0.1% bovine
serum albumin.
Immunofluorescence and scanning electron microscopy
After an adhesion assay, IE were smeared onto a microscope
slide, air-dried and fixed in ice-cold methanol for 5 minutes. After
re-hydration in PBS, vesicles were detected in a two-step
immunofluorescence assay (1/5,000 monoclonal mouse anti-PLAP
(Sigma-Aldrich A2951) followed by 1/1,000 AlexaFluor 488-
conjugated rabbit anti-mouse IgG (Invitrogen A11059); both for
1 h at room temperature). Slides were mounted in ProLong Gold
mounting medium with DAPI (Invitrogen). Images were acquired
on a LSM Confocal Olympus FV1000 microscope. For scanning
electron microscopy, cells were fixed post-assay for 15 minutes in
2.5% glutaraldehyde in 0.1 M sodium cacodylate pH 7.4, layered
on a glass coverslip, washed twice with water, air dried, coated
with platinum/palladium with a sputter coater (Polaron SC7640)
and imaged using La Trobe University Electron Microscopy
Facility’s field emission scanning electron microscope (FESEM,
Jeol JSM 6340F) operating at 5 keV.
Statistical analysis
Mean and standard errors to the mean were compared by
ANOVA using Stata software (version 10). P#0.05 denoted
statistical significance.
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